| 16 April 2013
In a long sought-after and potentially groundbreaking decision, the US Food and Drug Administration (FDA) has determined that generic non-abuse-resistant formulation of Purdue Pharma's drug Oxycontin Read More...
| 12 July 2012
A report in the New England Journal of Medicine (NEJM) found abuse of a OxyContin, a branded version of the opioid oxycodone, went down significantly between 2010 and the first quarter of 2012 as the Read More...
| 10 May 2012
Explosive allegations have emerged from two prominent Senators regarding marketing tactics used by a number of pharmaceutical companies, including Purdue Pharma, Endo Pharmaceuticals and Johnson & Read More...